Webb16 mars 2024 · Niraparib has shown promising results as a monotherapy in treatment … Webb55. A method of treating, inhibiting, reducing, ameliorating, and/or preventing a cancer and or metastasis in a subject comprising administering to a subject an adoptive immunothe
Formulation Diary
Webb2 apr. 2024 · Drug Profile Niraparib - Janssen/Merck/GlaxoSmithKline Alternative Names: GSK-3985771; JNJ-64091742; MK-4827; niraparib hydrochloride; Zejula; ZL 2306 Latest Information Update: 02 Apr 2024 Price : $50 * Buy Profile Adis is an information provider. We do not sell or distribute actual drugs. WebbName Niraparib tosylate monohydrate Drug Entry Niraparib. Niraparib is an orally active poly (ADP-ribose) polymerase (PARP) inhibitor. By blocking the enzymes responsible for DNA repair, niraparib induces cytotoxicity in cancer cells. 6 Niraparib is selective towards PARP-1 and PARP-2. 2 First approved by the FDA on March 27, … optus north lakes
Niraparib tosylate C26H28N4O4S - PubChem
Webb24 apr. 2024 · A process for preparing an enantiomerically enriched (S)-niraparib … Webb25 feb. 2024 · Niraparib (Monograph) Brand name: Zejula Drug class: Antineoplastic Agents - PARP Inhibitors - Poly (ADP-ribose) Polymerase Inhibitors VA class: AN900 Chemical name: 2- {4- [ (3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide Molecular formula: C 19 H 20 N 4 OC 19 H 20 N 4 O•C 7 H 8 O 3 S CAS number: 1038915-60-4 WebbEach ZEJULA capsule contains 159.4 mg niraparib tosylate monohydrate equivalent to 100 mg niraparib free base as the active ingredient. it is classified as BCS Class II compound. Due to low solubility, particle size distribution is controlled in the active substance specification. optus north lakes shopping centre